These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 22393126

  • 21. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
    Jarvis A, Allerston CK, Jia H, Herzog B, Garza-Garcia A, Winfield N, Ellard K, Aqil R, Lynch R, Chapman C, Hartzoulakis B, Nally J, Stewart M, Cheng L, Menon M, Tickner M, Djordjevic S, Driscoll PC, Zachary I, Selwood DL.
    J Med Chem; 2010 Mar 11; 53(5):2215-26. PubMed ID: 20151671
    [Abstract] [Full Text] [Related]

  • 22. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, Lacal PM, Graziani G.
    J Exp Clin Cancer Res; 2017 Aug 10; 36(1):106. PubMed ID: 28797294
    [Abstract] [Full Text] [Related]

  • 23. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
    Becker PM, Waltenberger J, Yachechko R, Mirzapoiazova T, Sham JS, Lee CG, Elias JA, Verin AD.
    Circ Res; 2005 Jun 24; 96(12):1257-65. PubMed ID: 15920019
    [Abstract] [Full Text] [Related]

  • 24. Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling.
    Bayliss AL, Sundararaman A, Granet C, Mellor H.
    Angiogenesis; 2020 Aug 24; 23(3):371-383. PubMed ID: 32274611
    [Abstract] [Full Text] [Related]

  • 25. Direct effect of bevacizumab on glioblastoma cell lines in vitro.
    Simon T, Coquerel B, Petit A, Kassim Y, Demange E, Le Cerf D, Perrot V, Vannier JP.
    Neuromolecular Med; 2014 Dec 24; 16(4):752-71. PubMed ID: 25113866
    [Abstract] [Full Text] [Related]

  • 26. Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.
    Paul-Samojedny M, Pudełko A, Suchanek-Raif R, Kowalczyk M, Fila-Daniłow A, Borkowska P, Kowalski J.
    Tumour Biol; 2015 May 24; 36(5):3263-77. PubMed ID: 25501707
    [Abstract] [Full Text] [Related]

  • 27. Anti-VEGFR2 monoclonal antibody(MSB0254) inhibits angiogenesis and tumor growth by blocking the signaling pathway mediated by VEGFR2 in glioblastoma.
    Chen S, Li X, Wang H, Chen G, Zhou Y.
    Biochem Biophys Res Commun; 2022 May 14; 604():158-164. PubMed ID: 35305420
    [Abstract] [Full Text] [Related]

  • 28. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE.
    Cell Death Differ; 2010 Mar 14; 17(3):499-512. PubMed ID: 19834490
    [Abstract] [Full Text] [Related]

  • 29. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    Kwiatkowski SC, Guerrero PA, Hirota S, Chen Z, Morales JE, Aghi M, McCarty JH.
    PLoS One; 2017 Mar 14; 12(9):e0185065. PubMed ID: 28938007
    [Abstract] [Full Text] [Related]

  • 30. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh A, Ruhrberg C.
    J Exp Med; 2014 Jun 02; 211(6):1167-83. PubMed ID: 24863063
    [Abstract] [Full Text] [Related]

  • 31. Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic.
    Gao F, Yang C.
    Curr Cancer Drug Targets; 2020 Jun 02; 20(1):3-18. PubMed ID: 31729943
    [Abstract] [Full Text] [Related]

  • 32. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation.
    Brossa A, Grange C, Mancuso L, Annaratone L, Satolli MA, Mazzone M, Camussi G, Bussolati B.
    Oncotarget; 2015 May 10; 6(13):11295-309. PubMed ID: 25948774
    [Abstract] [Full Text] [Related]

  • 33. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB, Yang S, Weng HY, Chen Q, Zhao XL, Fu WJ, Niu Q, Ping YF, Wang JM, Zhang X, Yao XH, Bian XW.
    Autophagy; 2017 Sep 02; 13(9):1528-1542. PubMed ID: 28812437
    [Abstract] [Full Text] [Related]

  • 34. Glioblastoma stem-like cells give rise to tumour endothelium.
    Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V.
    Nature; 2010 Dec 09; 468(7325):829-33. PubMed ID: 21102433
    [Abstract] [Full Text] [Related]

  • 35. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
    Peach CJ, Kilpatrick LE, Woolard J, Hill SJ.
    Br J Pharmacol; 2021 Jun 09; 178(12):2393-2411. PubMed ID: 33655497
    [Abstract] [Full Text] [Related]

  • 36. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE, Guarnaccia L, Cordiglieri C, Crisà FM, Caroli M, Locatelli M, Schisano L, Rampini P, Miozzo M, La Verde N, Riboni L, Campanella R, Marfia G.
    World Neurosurg; 2018 Dec 09; 120():e380-e391. PubMed ID: 30144594
    [Abstract] [Full Text] [Related]

  • 37. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y, Zhang X, Simons M.
    Arterioscler Thromb Vasc Biol; 2015 Feb 09; 35(2):421-9. PubMed ID: 25524775
    [Abstract] [Full Text] [Related]

  • 38. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.
    Shin SJ, Hwang JW, Ahn JB, Rha SY, Roh JK, Chung HC.
    Invest New Drugs; 2013 Feb 09; 31(1):1-13. PubMed ID: 22539090
    [Abstract] [Full Text] [Related]

  • 39. VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors.
    Grun D, Adhikary G, Eckert RL.
    Oncogene; 2016 Aug 18; 35(33):4379-87. PubMed ID: 26804163
    [Abstract] [Full Text] [Related]

  • 40. The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.
    Jeon HM, Shin YJ, Lee J, Chang N, Woo DH, Lee WJ, Nguyen D, Kang W, Cho HJ, Yang H, Lee JK, Sa JK, Lee Y, Kim DG, Purow BW, Yoon Y, Nam DH, Lee J.
    JCI Insight; 2023 Nov 08; 8(21):. PubMed ID: 37788099
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.